Reflections and Mendelian randomization analysis of patients with vitiligo and pancreatic cancer

Author:

Zhang Xusheng1,Liang Shicai1,Wang Xuebo1,Liu Kejun2,Chen Bendong2

Affiliation:

1. Ningxia Medical University

2. Ningxia Medical University General Hospital

Abstract

Abstract Objectives A special case of vitiligo patient with advanced pancreatic cancer was observed in our clinical practice, which prompted us to think about whether there is an association between the two diseases, and to further investigate whether there is a causal relationship between the two diseases, a two-sample Mendelian randomization analysis was performed. Methods In this study, two-sample Mendelian randomization (MR) analyses were performed using inverse variance weighted (IVW), weighted median, MR-Egger regression, Simple mode and Weighted mode. We used the publicly available Genome-wide association study (GWAS) summary statistics set on vitiligo of European origin (n=333064; Neale Lab) as the exposed GWAS; Samples of pancreatic cancer from the East Asian Biobank (total = 196187; cases = 442, controls = 195745; Neale Lab) were used as outcome. Results We screened 19 single nucleotide polymorphisms (SNPs) with genome-wide significance from GWASs on vitiligo as instrumental variables (P < 5.00E-06; linkage disequilibrium r2 < 0.1). Analysis of the results using various methods such as IVW, MR-Egger regression, Weighted median, Simple mode and Weighted mode did not support the existence of a causal relationship between vitiligo and pancreatic cancer (P > 0.05). Cochran's Q test and funnel plot showed no evidence of heterogeneity and asymmetry. And the intercept of MR-Egger analysis result = 0.017400347494319, P = 0.666 further suggests that there is no directional multiplicity of results. Conclusion The results of the MR analysis do not support a causal relationship between vitiligo and an increased risk of pancreatic cancer.

Publisher

Research Square Platform LLC

Reference22 articles.

1. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma;Duan Y;INT J MOL SCI,2022

2. Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World;King G;ADV THER,2022

3. Pancreatic Neuroendocrine Tumors. (Islet Cell Tumors) Treatment (PDQ(R)): Patient Version. 2002.

4. Synoptic CT scan reporting of pancreatic adenocarcinoma to align with international consensus guidelines on surgical resectability: a Victorian pilot;Pilgrim C;ANZ J SURG,2022

5. Storz P, Crawford HC. Carcinogenesis of Pancreatic Ductal Adenocarcinoma. GASTROENTEROLOGY 2020, 158(8):2072–2081.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3